Capture Green Lifestyles and Win Exciting Prizes: Huawei FusionSolar Creators’ Cup kicks off
SHENZHEN, China, March 26, 2025 /PRNewswire/ — When cameras illuminate solar PV, inspiring interactions between technology and nature emerge. On March 20, 2025, Huawei FusionSolar Creators’ Cup was launched, calling for creative works from global PV installers. The event is designed to
Alphamab Oncology Reports Full Year 2024 Financial Results and Business Highlights
SUZHOU, China, March 26, 2025 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2024 and highlighted recent business progress. Financial Summary For the year ended December 31, 2024, we recorded total revenue of RMB 640.08 mi
Science! SDU Researchers Identified the Membrane Receptor for Ceramide in Adipocytes
JINAN, China, March 26, 2025 /PRNewswire/ — Recently, Professor Sun Jinpeng’s team at Shandong University and collaborators published a research paper titled “Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte thermogenesis” in Science. This study e
Basketball community unites at FIBA 3×3 Asia Cup 2025 with activities for everyone, event boasts continued sustainability efforts
SINGAPORE, March 26, 2025 /PRNewswire/ — A week-long celebration of basketball will see the sports community come together at the Singapore Sports Hub for the FIBA 3×3 Asia Cup 2025 with exciting action on and off the court. The FIBA 3×3 Asia Cup 2025 is the eighth edition of the tou
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2024
SHANGHAI, March 25, 2025 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and vaccines, today announced i
Fosun Pharma Announces 2024 Annual Results
Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 25, 2025 /PRNewswire/ — On March 25, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”or “the Group”; Stock Code: 600196.SH, 02196.HK), a le
Ping An Health Releases 2024 ESG Report
Driving Sustainable Healthcare with “CARE” Strategy HONG KONG and SHANGHAI, March 25, 2025 /PRNewswire/ — Ping An Healthcare and Technology Company Limited (“Ping An Good Doctor“, “Ping An Health” or “the Company”, Stock Code: 1833.HK) recentl
LRQA strengthens its commitment to Supply Chain Sustainability at the Asia Pacific Supply Chain Sustainability Summit 2025
SINGAPORE, March 26, 2025 /PRNewswire/ — As stricter regulations, growing sustainable investment, and increasing customer demand for sustainability drive significant change, Asia Pacific is increasingly under the spotlight for global supply chains. Against this backdrop, LRQA was proud to spo
Jet MX Expands FAA 145CRS Maintenance Services with New Website
GOODYEAR, Ariz., March 25, 2025 /PRNewswire/ — Jet MX, Inc. announced multiple business updates for maintenance solutions available to turbine jet aircraft owners and operators for popular types including Learjet, King Air and Hawker. The KGYR-based business introduced updated branding togethe
Kelun-Biotech’s Radionuclide-Drug Conjugate (RDC) SKB107 Receives NMPA Approval For The Treatment of Bone Metastases in Solid Tumors
CHENGDU, China, March 25, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that the Company has received a clinical trial notice approving the investigational new drug application for a radionuclide-drug conjugate (RDC) drug SKB107 (f
